Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCastelnau Group Regulatory News (CGL)

Share Price Information for Castelnau Group (CGL)

Share Price is delayed by 15 minutes
Get Live Data
89.50    0.00 (0.00%)
Bid:
88.00
Ask:
91.00
Spread: 3.00 (3.409%)
Market Cap: £298.49m
CGL Live PriceLast checked at - London Stock Exchange

Intraday Castelnau Group Share Chart

Form 8.5 (EPT/RI)

11 Jan 2023 08:37

RNS Number : 3754M
Liberum Capital Limited
11 January 2023
Β 

Β 

FORM 8.5 (EPT/RI)

Β 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

Β 

1. KEY INFORMATION

Β 

(a) Name of exempt principal trader:

Liberum Capital Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Castelnau Group Limited

(c) Name of the party to the offer with which exempt principal trader is connected:

Broker to Castelnau Group Limited & Dignity plc

(d) Date dealing undertaken:

10th January 2023

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

No

Β 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

Β 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

Β 

The currency of all prices and other monetary amounts should be stated.

Β 

(a) Purchases and sales

Β 

Class of relevant security

Purchases/ sales

Β 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Β 

ORD NPV (Castelnau)

Β 

Β 

Purchase

Β 

Β 

30,000

Β 

0.73333

Β 

0.73333

Β 

ORD NPV (Castelnau)

Β 

Β 

Sale

Β 

Β 

20,000

Β 

0.73

Β 

0.73

Β 

Β 

(b) Cash-settled derivative transactions

Β 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

Β 

Β 

Β 

(c) Stock-settled derivative transactions (including options)

Β 

(i) Writing, selling, purchasing or varying

Β 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

Β 

(ii) Exercise

Β 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(d) Other dealings (including subscribing for new securities)

Β 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

Β 

Β 

Β 

Β 

Β 

Β 

3. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

Β 

None

Β 

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

Β 

None

Β 

Β 

Β 

Date of disclosure:

11th January 2023

Β 

Contact name:

Kathryn Saunders

Telephone number:

020 3100 2048

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.Β 

Β 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
FERGIGDBSXBDGXB
Date   Source Headline
15th Mar 20135:23 pmRNSAnnual Financial Report
15th Mar 20134:37 pmRNSPrice Monitoring Extension
1st Mar 20132:33 pmRNSTotal Voting Rights
22nd Feb 20132:51 pmRNSHolding(s) in Company
13th Feb 20132:47 pmRNSDirector/PDMR Shareholding
8th Feb 20139:00 amRNSDividend Declaration
8th Feb 20137:00 amRNSAnnual Financial Report
1st Feb 201312:28 pmRNSTotal Voting Rights
2nd Jan 201312:19 pmRNSBlocklisting Interim Review
2nd Jan 201312:17 pmRNSBlocklisting Interim Review
2nd Jan 201312:14 pmRNSTotal Voting Rights
21st Dec 20124:51 pmRNSDirector/PDMR Shareholding
21st Dec 20124:30 pmRNSDirector/PDMR Shareholding
18th Dec 20127:00 amRNSSandy storm estimates
3rd Dec 201212:14 pmRNSTotal Voting Rights
22nd Nov 20128:00 amRNSNew Group Claims Director
22nd Nov 20128:00 amRNSInvestor Day
12th Nov 20127:00 amRNSInterim Management Statement
1st Nov 20124:05 pmRNSTotal Voting Rights
8th Oct 20124:04 pmRNSDirector/PDMR Shareholding
1st Oct 20122:56 pmRNSTotal Voting Rights
25th Sep 201212:00 pmRNSFinancial Calendar
7th Sep 201212:25 pmRNSDirector/PDMR Shareholding
3rd Sep 20122:38 pmRNSTotal Voting Rights
7th Aug 20122:48 pmRNSDirector/PDMR Shareholding
6th Aug 201211:09 amRNSDirector Declaration
6th Aug 20129:59 amRNSDividend Declaration
6th Aug 20127:00 amRNSHalf Yearly Report
1st Aug 201210:49 amRNSTotal Voting Rights
3rd Jul 20127:00 amRNSTotal Voting Rights
2nd Jul 20122:56 pmRNSBlocklisting Interim Review
2nd Jul 20122:54 pmRNSBlocklisting Interim Review
28th Jun 20124:31 pmRNSDirector/PDMR Shareholding
7th Jun 20122:12 pmRNSDirector/PDMR Shareholding
1st Jun 201210:52 amRNSTotal Voting Rights
11th May 20127:00 amRNSInterim Management Statement
1st May 20124:03 pmRNSTotal Voting Rights
12th Apr 201212:08 pmRNSHolding(s) in Company
10th Apr 201212:21 pmRNSAnnual Information Update
2nd Apr 20124:23 pmRNSDirector/PDMR Shareholding
2nd Apr 20124:21 pmRNSTotal Voting Rights
16th Mar 20122:28 pmRNSAnnual Financial Report
13th Mar 20122:29 pmRNSDirector/PDMR Shareholding
1st Mar 20124:19 pmRNSTotal Voting Rights
21st Feb 20123:00 pmRNSDirector/PDMR Shareholding
16th Feb 20124:21 pmRNSDirector/PDMR Shareholding
15th Feb 20125:15 pmRNSDirector/PDMR Shareholding
13th Feb 20123:09 pmRNSDirector/PDMR Shareholding
13th Feb 20123:03 pmRNSDirector/PDMR Shareholding
9th Feb 20129:00 amRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.